<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36451824</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Cytokine expression in rhinovirus- vs. respiratory syncytial virus-induced first wheezing episode and its relation to clinical course.</ArticleTitle><Pagination><StartPage>1044621</StartPage><MedlinePgn>1044621</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1044621</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1044621</ELocationID><Abstract><AbstractText>Rhinovirus (RV) and respiratory syncytial virus (RSV) are common causes of bronchiolitis. Unlike an RSV etiology, an RV etiology is associated with a markedly increased risk of asthma. We investigated the cytokine profiles of RV- and RSV-induced first wheezing episode and their correlation with prognosis. We recruited 52 sole RV- and 11 sole RSV-affected children with a severe first wheezing episode. Peripheral blood mononuclear cells (PBMCs) were isolated during acute illness and 2 weeks later and stimulated <i>in vitro</i> with anti-CD3/anti-CD28. Culture medium samples were analyzed for 56 different cytokines by multiplex ELISA. Recurrences were prospectively followed for 4 years. In adjusted analyses, the cytokine response from PBMCs in the RV group was characterized by decreased expression of interleukin 1 receptor antagonist (IL-1RA), interleukin 1 beta (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) and increased expression of eosinophil chemotactic protein 2 (eotaxin-2), thymus- and activation-regulated chemokine (TARC), and epithelial-derived neutrophil-activating peptide 78 (ENA-78) in the acute phase and increased expression of fractalkine in the convalescent phase compared to those in the RSV group. An analysis of the change in cytokine expression between study points revealed an increased expression of fractalkine and IL-1β and decreased expression of I-309 (CCL1) and TARC in the RV group compared to those in the RSV group.. Considering hospitalization time, a significant non-adjusted group × cytokine interaction was observed in the levels of interferon gamma (IFN-γ), macrophage-derived chemokine (MDC), IL-1RA, and vascular endothelial growth factor (VEGF), indicating that a higher expression of cytokine was associated with shorter hospitalization time in the RSV group but not in the RV group. A significant interaction was also found in interleukin 6 (IL-6), but the cytokine response was not associated with hospitalization time in the RSV or RV group. In the RV group, increased expression of I-309 (CCL1) and TARC was associated with fewer relapses within 2 months, and decreased expression of interleukin 13 (IL-13) and increased expression of I-309 (CCL1) were associated with less relapses within 12 months. Differences in cytokine response from PBMCs were observed between RV- and RSV-induced first severe wheezing episode. Our findings also reveal new biomarkers for short- and medium-term prognosis in first-time wheezing children infected with RV or RSV.</AbstractText><CopyrightInformation>Copyright © 2022 Hurme, Komulainen, Tulkki, Leino, Rückert, Turunen, Vuorinen, Akdis, Akdis and Jartti.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurme</LastName><ForeName>Pekka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komulainen</LastName><ForeName>Miisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulkki</LastName><ForeName>Marleena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leino</LastName><ForeName>Annamari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rückert</LastName><ForeName>Beate</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turunen</LastName><ForeName>Riitta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New Children's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuorinen</LastName><ForeName>Tytti</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akdis</LastName><ForeName>Mübeccel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akdis</LastName><ForeName>Cezmi A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jartti</LastName><ForeName>Tuomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PEDEGO Research Unit, Medical Research Center, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054428">Chemokine CX3CL1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053590">Interleukin 1 Receptor Antagonist Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054428" MajorTopicYN="N">Chemokine CX3CL1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053590" MajorTopicYN="N">Interleukin 1 Receptor Antagonist Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018111" MajorTopicYN="Y">Pneumovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bronchiolitis</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">wheezing</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>2</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36451824</ArticleId><ArticleId IdType="pmc">PMC9702984</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1044621</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jartti T, Smits HH, Bønnelykke K, Bircan O, Elenius V, Konradsen JR, et al. . Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy: Eur J Allergy Clin Immunol (2019) 74:40–52. doi: 10.1111/all.13624</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13624</ArticleId><ArticleId IdType="pmc">PMC6587559</ArticleId><ArticleId IdType="pubmed">30276826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al. . Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med (2012) 166:700. doi: 10.1001/archpediatrics.2011.1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpediatrics.2011.1669</ArticleId><ArticleId IdType="pmc">PMC3394902</ArticleId><ArticleId IdType="pubmed">22473882</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas O, Erkkola R, Bergroth E, Hasegawa K, Mansbach JM, Piedra PA, et al. . Severe bronchiolitis profiles and risk of asthma development in Finnish children. J Allergy Clin Immunol (2021) 149(4):1281–1285.e1. doi: 10.1016/J.JACI.2021.08.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2021.08.035</ArticleId><ArticleId IdType="pubmed">34624392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bønnelykke K, Sleiman P, Nielsen K, Kreiner-Møller E, Mercader JM, Belgrave D, et al. . A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet (2014) 46:51–5. doi: 10.1038/NG.2830</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NG.2830</ArticleId><ArticleId IdType="pubmed">24241537</ArticleId></ArticleIdList></Reference><Reference><Citation>Calışkan M, Bochkov YA, Kreiner-Møller E, Bønnelykke K, Stein MM, Du G, et al. . Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med (2013) 368:1398–407. doi: 10.1056/NEJMOA1211592</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMOA1211592</ArticleId><ArticleId IdType="pmc">PMC3755952</ArticleId><ArticleId IdType="pubmed">23534543</ArticleId></ArticleIdList></Reference><Reference><Citation>Makrinioti H, Hasegawa K, Lakoumentas J, Xepapadaki P, Tsolia M, Castro-Rodriguez JA, et al. . The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma-a systematic review and meta-analysis. Pediatr Allergy Immunol (2022) 33:e13741. doi: 10.1111/PAI.13741</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/PAI.13741</ArticleId><ArticleId IdType="pubmed">35338734</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale J, Jayaraman A, Jackson DJ, Macintyre JDR, Edwards MR, Walton RP, et al. . Rhinovirus induced IL-25 in asthma exacerbation drives type-2 immunity and allergic pulmonary inflammation. Sci Transl Med (2014) 6:256ra134. doi: 10.1126/SCITRANSLMED.3009124</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCITRANSLMED.3009124</ArticleId><ArticleId IdType="pmc">PMC4246061</ArticleId><ArticleId IdType="pubmed">25273095</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Rajput C, Hong JY, Lei J, Hinde JL, Wu Q, et al. . The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol (2017) 199:1308–18. doi: 10.4049/JIMMUNOL.1700216</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/JIMMUNOL.1700216</ArticleId><ArticleId IdType="pmc">PMC5548608</ArticleId><ArticleId IdType="pubmed">28701507</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca W, Lukacs NW, Elesela S, Malinczak CA. Role of ILC2 in viral-induced lung pathogenesis. Front Immunol (2021) 12:675169. doi: 10.3389/FIMMU.2021.675169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.675169</ArticleId><ArticleId IdType="pmc">PMC8092393</ArticleId><ArticleId IdType="pubmed">33953732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemanske RF, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. . Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 116:571–7. doi: 10.1016/j.jaci.2005.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.06.024</ArticleId><ArticleId IdType="pubmed">16159626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Hartert TV. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti-Infective Ther (2011) 9:731–45. doi: 10.1586/eri.11.92</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.11.92</ArticleId><ArticleId IdType="pmc">PMC3215509</ArticleId><ArticleId IdType="pubmed">21905783</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol (2017) 140:895–906. doi: 10.1016/j.jaci.2017.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC7172811</ArticleId><ArticleId IdType="pubmed">28987219</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Nieminen R, Vuorinen T, Lehtinen P, Vahlberg T, Gern J, et al. . Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. J Allergy Clin Immunol (2015) 135:691–8.e9. doi: 10.1016/j.jaci.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC7112325</ArticleId><ArticleId IdType="pubmed">25129681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurme P, Homil K, Lehtinen P, Turunen R, Vahlberg T, Vuorinen T, et al. . Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode. Clin Exp Allergy (2021) 51(9):1121–32. doi: 10.1111/CEA.13960</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/CEA.13960</ArticleId><ArticleId IdType="pubmed">34062027</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Lehtinen P, Vuorinen T, Osterback R, van den Hoogen B, Osterhaus ADME, et al. . Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis (2004) 10:1095–101. doi: 10.3201/eid1006.030629</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1006.030629</ArticleId><ArticleId IdType="pmc">PMC3323183</ArticleId><ArticleId IdType="pubmed">15207063</ArticleId></ArticleIdList></Reference><Reference><Citation>Turunen R, Koistinen A, Vuorinen T, Arku B, Söderlund-Venermo M, Ruuskanen O, et al. . The first wheezing episode: Respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol (2014) 25:796–803. doi: 10.1111/pai.12318</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12318</ArticleId><ArticleId IdType="pmc">PMC7167827</ArticleId><ArticleId IdType="pubmed">25444257</ArticleId></ArticleIdList></Reference><Reference><Citation>Turunen R, Jartti T, Bochkov YA, Gern JE, Vuorinen T. Rhinovirus species and clinical characteristics in the first wheezing episode in children. J Med Virol (2016) 88:2059–68. doi: 10.1002/JMV.24587</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.24587</ArticleId><ArticleId IdType="pmc">PMC5140033</ArticleId><ArticleId IdType="pubmed">27232888</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, Hyypiä T. Rhinovirus transmission within families with children: Incidence of symptomatic and asymptomatic infections. J Infect Dis (2008) 197:382–9. doi: 10.1086/525542</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/525542</ArticleId><ArticleId IdType="pubmed">18248302</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterback R, Tevaluoto T, Ylinen T, Peltola V, Susi P, Hyypiä T, et al. . Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic acid probes. J Clin Microbiol (2013) 51:3960–7. doi: 10.1128/JCM.01646-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01646-13</ArticleId><ArticleId IdType="pmc">PMC3838063</ArticleId><ArticleId IdType="pubmed">24048533</ArticleId></ArticleIdList></Reference><Reference><Citation>Söderlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P, et al. . Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerging Infect Dis (2009) 15:1423–30. doi: 10.3201/eid1509.090204</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1509.090204</ArticleId><ArticleId IdType="pmc">PMC2819894</ArticleId><ArticleId IdType="pubmed">19788810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern JE, Visness CM, Gergen PJ, Wood RA, Bloomberg GR, O’Connor GT, et al. . The urban environment and childhood asthma (URECA) birth cohort study: design, methods, and study population. BMC Pulm Med (2009) 9:17. doi: 10.1186/1471-2466-9-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2466-9-17</ArticleId><ArticleId IdType="pmc">PMC2689166</ArticleId><ArticleId IdType="pubmed">19426496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramratnam SK, Visness CM, Jaffee KF, Bloomberg GR, Kattan M, Sandel MT, et al. . Relationships among maternal stress and depression, type 2 responses, and recurrent wheezing at age 3 years in low-income urban families. Am J Respir Crit Care Med (2017) 195:674–81. doi: 10.1164/RCCM.201602-0272OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/RCCM.201602-0272OC</ArticleId><ArticleId IdType="pmc">PMC5363974</ArticleId><ArticleId IdType="pubmed">27654103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehmi R, Lim HF, Mukherjee M, Huang C, Radford K, Newbold P, et al. . Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma. J Allergy Clin Immunol (2018) 141:1529–1532.e8. doi: 10.1016/J.JACI.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2018.01.008</ArticleId><ArticleId IdType="pubmed">29382593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolbinger F, Loesche C, Valentin MA, Jiang X, Cheng Y, Jarvis P, et al. . β-defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. J Allergy Clin Immunol (2017) 139:923–932.e8. doi: 10.1016/J.JACI.2016.06.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2016.06.038</ArticleId><ArticleId IdType="pubmed">27502297</ArticleId></ArticleIdList></Reference><Reference><Citation>Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, et al. . Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory b-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. Lancet Oncol (2019) 20:1710–8. doi: 10.1016/S1470-2045(19)30493-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(19)30493-0</ArticleId><ArticleId IdType="pmc">PMC7480957</ArticleId><ArticleId IdType="pubmed">31606419</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol (2015) 135:626–35. doi: 10.1016/J.JACI.2014.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2014.11.001</ArticleId><ArticleId IdType="pubmed">25528359</ArticleId></ArticleIdList></Reference><Reference><Citation>Provost V, Larose M-C, Langlois A, Rola-Pleszczynski M, Flamand N, Laviolette M. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. J Leukoc Biol (2013) 94:213–22. doi: 10.1189/JLB.0212074</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/JLB.0212074</ArticleId><ArticleId IdType="pubmed">23532518</ArticleId></ArticleIdList></Reference><Reference><Citation>Catherine J, Roufosse F. What does elevated TARC/CCL17 expression tell us about eosinophilic disorders? Semin Immunopathol (2021) 43:439–58. doi: 10.1007/S00281-021-00857-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00281-021-00857-W</ArticleId><ArticleId IdType="pmc">PMC8132044</ArticleId><ArticleId IdType="pubmed">34009399</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Li N, Yang Z, Li H, Zheng H, Yang J, et al. . Role of CXCL5 in regulating chemotaxis of innate and adaptive leukocytes in infected lungs upon pulmonary influenza infection. Front Immunol (2021) 12:785457. doi: 10.3389/FIMMU.2021.785457</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.785457</ArticleId><ArticleId IdType="pmc">PMC8637413</ArticleId><ArticleId IdType="pubmed">34868067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Agarwal M, Ling S, Teitz-Tennenbaum S, Zemans RL, Osterholzer JJ, et al. . Diverse injury pathways induce alveolar epithelial cell CCL2/12, which promotes lung fibrosis. Am J Respir Cell Mol Biol (2020) 62:622–32. doi: 10.1165/RCMB.2019-0297OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/RCMB.2019-0297OC</ArticleId><ArticleId IdType="pmc">PMC7193786</ArticleId><ArticleId IdType="pubmed">31922885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: A review. Clin Chim Acta (2010) 411:1570–9. doi: 10.1016/J.CCA.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CCA.2010.07.006</ArticleId><ArticleId IdType="pubmed">20633546</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol (2021) 101:107598. doi: 10.1016/J.INTIMP.2021.107598</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.INTIMP.2021.107598</ArticleId><ArticleId IdType="pmc">PMC8135227</ArticleId><ArticleId IdType="pubmed">34233864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra-Filardi E, Nieto C, Domínguez-Soto Á., Barroso R, Sánchez-Mateos P, Puig-Kroger A, et al. . CCL2 shapes macrophage polarization by GM-CSF and m-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol (2014) 192:3858–67. doi: 10.4049/JIMMUNOL.1302821</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/JIMMUNOL.1302821</ArticleId><ArticleId IdType="pubmed">24639350</ArticleId></ArticleIdList></Reference><Reference><Citation>Díaz PV, Valdivia G, Gaggero AA, Bono MR, Zepeda G, Rivas M, et al. . Pro-inflammatory cytokines in nasopharyngeal aspirate from hospitalized children with respiratory syncytial virus infection with or without rhinovirus bronchiolitis, and use of the cytokines as predictors of illness severity. Medicine (2015) 94:e1512. doi: 10.1097/MD.0000000000001512</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001512</ArticleId><ArticleId IdType="pmc">PMC4616851</ArticleId><ArticleId IdType="pubmed">26426613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastre B, García-García ML, Calvo C, Casas I, Rodrigo-Muñoz JM, Cañas JA, et al. . Immune recovery following bronchiolitis is linked to a drop in cytokine and LTC4 levels. Pediatr Res (2020) 87:581–7. doi: 10.1038/S41390-019-0606-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41390-019-0606-2</ArticleId><ArticleId IdType="pmc">PMC7086521</ArticleId><ArticleId IdType="pubmed">31600771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Paul-Anttila M, Lehtinen P, Parikka V, Vuorinen T, Simell O, et al. . Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: An observational study. Respir Res (2009) 10:85. doi: 10.1186/1465-9921-10-85</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-10-85</ArticleId><ArticleId IdType="pmc">PMC2762974</ArticleId><ArticleId IdType="pubmed">19781072</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberle JH, Aberle SW, Rebhandl W, Pracher E, Kundi M, Popow-Kraupp T. Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol (2004) 137:146. doi: 10.1111/J.1365-2249.2004.02504.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1365-2249.2004.02504.X</ArticleId><ArticleId IdType="pmc">PMC1809072</ArticleId><ArticleId IdType="pubmed">15196255</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh DE, Park SH, Choi HJ, Kim YH. Comparison of cytokine expression profiles in infants with a rhinovirus induced lower respiratory tract infection with or without wheezing: a comparison with respiratory syncytial virus. Kor J Pediatr (2017) 60:296–301. doi: 10.3345/KJP.2017.60.9.296</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/KJP.2017.60.9.296</ArticleId><ArticleId IdType="pmc">PMC5638836</ArticleId><ArticleId IdType="pubmed">29042873</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Qu X, Liu X, Huan C, Wang H, Zhao Z, et al. . GBP5 is an interferon-induced inhibitor of respiratory syncytial virus. J Virol (2020) 94:e01407–20. doi: 10.1128/JVI.01407-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01407-20</ArticleId><ArticleId IdType="pmc">PMC7565618</ArticleId><ArticleId IdType="pubmed">32796072</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter JR, Sutton JM, Belizaire RM, Friend LA, Schuster RM, Johannigman TA, et al. . Macrophage-derived chemokine (MDC/CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation. Shock (2014) 42:525. doi: 10.1097/SHK.0000000000000253</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000253</ArticleId><ArticleId IdType="pmc">PMC4236272</ArticleId><ArticleId IdType="pubmed">25136780</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai K, Kimura H, Miyaji Y, Tsukagoshi H, Yoshizumi M, Sasaki-Sakamoto T, et al. . MIP-1α level in nasopharyngeal aspirates at the first wheezing episode predicts recurrent wheezing. J Allergy Clin Immunol (2016) 137:774–81. doi: 10.1016/J.JACI.2015.08.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2015.08.032</ArticleId><ArticleId IdType="pubmed">26494023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitcharoensakkul M, Bacharier LB, Yin-Declue H, Boomer JS, Sajol G, Leung MK, et al. . Impaired tumor necrosis factor-α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze. Immunity Inflammation Dis (2020) 8:30–9. doi: 10.1002/IID3.281</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/IID3.281</ArticleId><ArticleId IdType="pmc">PMC7016853</ArticleId><ArticleId IdType="pubmed">31901157</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton N, Jackson DJ, Nikonova AA, Hingley-Wilson S, Khaitov M, del Rosario A, et al. . Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma. PloS One (2017) 12:e0183864. doi: 10.1371/JOURNAL.PONE.0183864</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0183864</ArticleId><ArticleId IdType="pmc">PMC5578648</ArticleId><ArticleId IdType="pubmed">28859129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagome K, Bochkov YA, Ashraf S, Brockman-Schneider RA, Evans MD, Pasic TR, et al. . Effects of rhinovirus species on viral replication and cytokine production. J Allergy Clin Immunol (2014) 134:332–41. doi: 10.1016/J.JACI.2014.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACI.2014.01.029</ArticleId><ArticleId IdType="pmc">PMC4119842</ArticleId><ArticleId IdType="pubmed">24636084</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenes-Chacon H, Garcia-Mauriño C, Moore-Clingenpeel M, Mertz S, Ye F, Cohen DM, et al. . Age-dependent interactions among clinical characteristics, viral loads and disease severity in young children with respiratory syncytial virus infection. Pediatr Infect Dis J (2021) 40:116–22. doi: 10.1097/INF.0000000000002914</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002914</ArticleId><ArticleId IdType="pmc">PMC7808270</ArticleId><ArticleId IdType="pubmed">33433159</ArticleId></ArticleIdList></Reference><Reference><Citation>Trickett A, Kwan YL. T Cell stimulation and expansion using anti-CD3/CD28 beads. J Immunol Methods (2003) 275:251–5. doi: 10.1016/S0022-1759(03)00010-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-1759(03)00010-3</ArticleId><ArticleId IdType="pubmed">12667688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor N, Nehar-Belaid D, Grassmann JDS, Stoeckius M, Smibert P, Stitzel ML, et al. . Single cell analysis of blood mononuclear cells stimulated through either LPS or anti-CD3 and anti-CD28. Front Immunol (2021) 12:636720. doi: 10.3389/FIMMU.2021.636720</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.636720</ArticleId><ArticleId IdType="pmc">PMC8010670</ArticleId><ArticleId IdType="pubmed">33815388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>